<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id><journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id><journal-title-group><journal-title>The Journal of Headache and Pain</journal-title></journal-title-group><issn pub-type="ppub">1129-2369</issn><issn pub-type="epub">1129-2377</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Milan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17955170</article-id><article-id pub-id-type="pmc">3476152</article-id><article-id pub-id-type="publisher-id">414</article-id><article-id pub-id-type="doi">10.1007/s10194-007-0414-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original</subject></subj-group></article-categories><title-group><article-title>The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headache</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kemal Erdemoglu</surname><given-names>A.</given-names></name><address><phone>+90-318-2252486/197</phone><fax>+90-318-2252819</fax><email>akerdemoglu@yahoo.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Varlibas</surname><given-names>Ayhan</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Department of Neurology, Kirikkale University Faculty of Medicine, Kirikkale, 07100 Turkey </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>10</month><year>2007</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2007</year></pub-date><volume>8</volume><issue>5</issue><fpage>294</fpage><lpage>300</lpage><history><date date-type="received"><day>30</day><month>6</month><year>2007</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; Springer-Verlag Italia 2007</copyright-statement></permissions><abstract id="Abs1"><p>The objective of this study was to investigate the long-term efficacy and safety of botulinum toxin type-A (BoNT-A) for refractory chronic tension-type headache (CTTH). An open-label, prospective study was carried out in the Department of Neurology of Kirikkale University on 28 patients (8 males, 20 females), mean age 35.6 years, diagnosed with moderate/severe CTTH refractory to preventive medications. Each patient received BoNT-A injections once in pericranial muscles. Efficacy and safety data were analysed for 28 refractory CTTH patients who were receiving concomitant headache prophylactic medications at baseline and during the study. The main outcome parameters were reduction of headache frequency and intensity over 1 year. Both parameters were significantly decreased (<italic>p</italic>&#x0003c;0.05) by the end of the study. Sixty-four percent of patients reported complete headache relief at the final visit, compared to 7% CTTH persisted. BoNT-A also resulted in significant reductions in analgesic consumption (<italic>p</italic>&#x0003c;0.05). Adverse effects were transient and local. BoNT-A was found to be an effective and safe treatment for refractory CTTH patients with concomitant headache prophylactic medications, resulting in significant reductions in headache frequency, intensity and analgesic consumption which persisted up to 1 year.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Botulinum toxin type-A (BoNT-A)</kwd><kwd>Chronic tension-type headache (CTTH)</kwd><kwd>Headache frequency</kwd><kwd>Headache intensity</kwd><kwd>Refractory</kwd><kwd>Treatment</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Italia 2007</meta-value></custom-meta></custom-meta-group></article-meta></front><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>L.</given-names></name></person-group><article-title>Tension-type, the forgotten headache. How to recognize this common but undertreated condition</article-title><source>Postgrad Med</source><year>2002</year><volume>111</volume><fpage>25</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.3810/pgm.2002.04.1165</pub-id><pub-id pub-id-type="pmid">11985132</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulman</surname><given-names>E.A.</given-names></name></person-group><article-title>Overview of tension-type headache</article-title><source>Curr Pain Headache Rep</source><year>2001</year><volume>5</volume><fpage>454</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1007/s11916-001-0057-3</pub-id><pub-id pub-id-type="pmid">11560811</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>R.T.F.</given-names></name></person-group><article-title>Prevalence of migraine, tension-type headache, and other headaches in Hong Kong</article-title><source>Headache</source><year>2000</year><volume>40</volume><fpage>473</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2000.00071.x</pub-id><pub-id pub-id-type="pmid">10849044</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gobel</surname><given-names>H.</given-names></name><name><surname>Petersen-Braun</surname><given-names>M.</given-names></name><name><surname>Soyka</surname><given-names>D.</given-names></name></person-group><article-title>The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society</article-title><source>Cephalalgia</source><year>1994</year><volume>14</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1994.1402097.x</pub-id><pub-id pub-id-type="pmid">8062362</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryse-Phillips</surname><given-names>W.</given-names></name><name><surname>Findlay</surname><given-names>H.</given-names></name><name><surname>Tugwell</surname><given-names>P.</given-names></name><etal/></person-group><article-title>A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache</article-title><source>Can J Neurol Sci</source><year>1992</year><volume>19</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">1393842</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>B.K.</given-names></name><name><surname>Jensen</surname><given-names>R.</given-names></name><name><surname>Schroll</surname><given-names>M.</given-names></name><name><surname>Olesen</surname><given-names>J.</given-names></name></person-group><article-title>Epidemiology of headache in a general population &#x02014; a prevalence study</article-title><source>J Clin Epidemiol</source><year>1991</year><volume>44</volume><fpage>1147</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1016/0895-4356(91)90147-2</pub-id><pub-id pub-id-type="pmid">1941010</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>B.K.</given-names></name><name><surname>Jensen</surname><given-names>R.</given-names></name><name><surname>Olesen</surname><given-names>J.</given-names></name></person-group><article-title>Impact of headache on sickness absence and utilisation of medical services: a Danish population study</article-title><source>J Epidemiol Community Health</source><year>1992</year><volume>46</volume><fpage>443</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1136/jech.46.4.443</pub-id><pub-id pub-id-type="pmid">1431724</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>B.J.</given-names></name><name><surname>Stewart</surname><given-names>W.F.</given-names></name><name><surname>Simon</surname><given-names>D.</given-names></name><name><surname>Lipton</surname><given-names>R.B.</given-names></name></person-group><article-title>Epidemiology of tension-type headache</article-title><source>JAMA</source><year>1998</year><volume>279</volume><fpage>381</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1001/jama.279.5.381</pub-id><pub-id pub-id-type="pmid">9459472</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>K.</given-names></name><name><surname>Norup</surname><given-names>M.</given-names></name></person-group><article-title>Experimental pain in human muscle induced by hypertonic saline, potassium and acidity</article-title><source>Cephalalgia</source><year>1992</year><volume>12</volume><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1992.1202101.x</pub-id><pub-id pub-id-type="pmid">1576638</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollnik</surname><given-names>J.D.</given-names></name><name><surname>Karst</surname><given-names>M.</given-names></name><name><surname>Fink</surname><given-names>M.</given-names></name><name><surname>Dengler</surname><given-names>R.</given-names></name></person-group><article-title>Coping strategies in episodic and chronic tension-type headache</article-title><source>Headache</source><year>2001</year><volume>41</volume><fpage>297</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2001.111006297.x</pub-id><pub-id pub-id-type="pmid">11264691</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holroyd</surname><given-names>K.A.</given-names></name><name><surname>Stensland</surname><given-names>M.</given-names></name><name><surname>Lipchik</surname><given-names>G.L.</given-names></name><etal/></person-group><article-title>Psychosocial correlates and impact of chronic tension-type headaches</article-title><source>Headache</source><year>2000</year><volume>40</volume><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2000.00001.x</pub-id><pub-id pub-id-type="pmid">10759896</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borodic</surname><given-names>G.E.</given-names></name><name><surname>Acquadro</surname><given-names>M.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group><article-title>Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects</article-title><source>Expert Opin Investig Drugs</source><year>2001</year><volume>10</volume><fpage>1531</fpage><lpage>1544</lpage><pub-id pub-id-type="doi">10.1517/13543784.10.8.1531</pub-id><pub-id pub-id-type="pmid">11772268</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smuts</surname><given-names>J.A.</given-names></name><name><surname>Baker</surname><given-names>M.K.</given-names></name><name><surname>Smuts</surname><given-names>H.M.</given-names></name><etal/></person-group><article-title>Prophylactic treatment of chronic tension-type headache using botulinum toxin type A</article-title><source>Eur J Neurol</source><year>1999</year><volume>6</volume><issue>suppl4</issue><fpage>S99</fpage><lpage>S102</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1331.1999.tb00044.x</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evers</surname><given-names>S.</given-names></name><name><surname>Vollmer-Haase</surname><given-names>J.</given-names></name><name><surname>Schwaag</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Botulinum toxin A in the prophylactic treatment of migraine&#x02014;a randomized, double-blind, placebo-controlled study</article-title><source>Cephalalgia</source><year>2004</year><volume>24</volume><fpage>838</fpage><lpage>843</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2004.00754.x</pub-id><pub-id pub-id-type="pmid">15377314</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>S.</given-names></name><name><surname>Mathew</surname><given-names>N.</given-names></name><name><surname>Saper</surname><given-names>J.</given-names></name><name><surname>Jenkins</surname><given-names>S. f.</given-names></name><collab>the BOTOX&#x000ae; Migraine Clinical Research Group</collab></person-group><article-title>Botulinum toxin type A as a migraine preventive treatment</article-title><source>Headache</source><year>2000</year><volume>40</volume><fpage>445</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2000.00066.x</pub-id><pub-id pub-id-type="pmid">10849039</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relja</surname><given-names>M.A.</given-names></name></person-group><article-title>Treatment of tension-type headache by local injection of botulinum toxin</article-title><source>Euro J Neurol</source><year>1997</year><volume>4</volume><issue>Suppl2</issue><fpage>71</fpage><lpage>72</lpage></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relja</surname><given-names>M.A.</given-names></name></person-group><article-title>Treatment of tension-type headache with botulinum toxin: 1-year follow-up</article-title><source>Cephalalgia</source><year>2000</year><volume>20</volume><fpage>336</fpage></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ondo</surname><given-names>W.G.</given-names></name><name><surname>Vuong</surname><given-names>K.D.</given-names></name><name><surname>Derman</surname><given-names>H.S.</given-names></name></person-group><article-title>Botulinum toxin A for chronic daily headache: a randomized, place-bo-controlled, parallel design study</article-title><source>Cephalalgia</source><year>2004</year><volume>24</volume><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2004.00641.x</pub-id><pub-id pub-id-type="pmid">14687015</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte-Mattler</surname><given-names>W.J.</given-names></name><name><surname>Wieser</surname><given-names>T.</given-names></name><name><surname>Zierz</surname><given-names>S.</given-names></name></person-group><article-title>Treatment of tensiontype headache with botulinum toxin: a pilot study</article-title><source>Eur J Med Res</source><year>1999</year><volume>4</volume><fpage>183</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">10336407</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>W.J.</given-names></name><name><surname>Slowey</surname><given-names>E.</given-names></name><name><surname>Fravi</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double blind, placebo-controlled trial</article-title><source>Headache</source><year>2001</year><volume>41</volume><fpage>658</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2001.041007658.x</pub-id><pub-id pub-id-type="pmid">11554953</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollnik</surname><given-names>J.D.</given-names></name><name><surname>Tanneberger</surname><given-names>O.</given-names></name><name><surname>Schubert</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study</article-title><source>Headache</source><year>2000</year><volume>40</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2000.00044.x</pub-id><pub-id pub-id-type="pmid">10759934</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>S.D.</given-names></name><name><surname>G&#x000f6;bel</surname><given-names>H.</given-names></name><name><surname>Jensen</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study</article-title><source>Cephalalgia</source><year>2006</year><volume>26</volume><fpage>790</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2006.01114.x</pub-id><pub-id pub-id-type="pmid">16776693</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burch</surname><given-names>C.M.</given-names></name><name><surname>Kokoska</surname><given-names>M.S.</given-names></name><name><surname>Glaser</surname><given-names>D.A.</given-names></name><name><surname>Hollenbeak</surname><given-names>C.S.</given-names></name></person-group><article-title>Treatment of frontal tension headaches with botulinum toxin A</article-title><source>Cephalalgia</source><year>2001</year><volume>21</volume><fpage>486</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.2001.00030.x</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relja</surname><given-names>M.A.</given-names></name><name><surname>Telarovic</surname><given-names>S.</given-names></name></person-group><article-title>Botulinum toxin in tension-type headache</article-title><source>J Neurol</source><year>2004</year><volume>251</volume><issue>Suppl</issue><fpage>1/12</fpage><lpage>1/14</lpage><pub-id pub-id-type="pmid">14999483</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mennini</surname><given-names>F.S.</given-names></name><name><surname>Fioravanti</surname><given-names>L.</given-names></name><name><surname>Piasini</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache</article-title><source>J Headache Pain</source><year>2004</year><volume>5</volume><fpage>188</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1007/s10194-004-0099-5</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farinelli</surname><given-names>I.</given-names></name><name><surname>Coloprisco</surname><given-names>G.</given-names></name><name><surname>Filippis</surname><given-names>S.</given-names></name><name><surname>Martelletti</surname><given-names>P.</given-names></name></person-group><article-title>Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience</article-title><source>J Headache Pain</source><year>2006</year><volume>7</volume><fpage>407</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1007/s10194-006-0344-9</pub-id><pub-id pub-id-type="pmid">17149565</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>N.</given-names></name><name><surname>Frishberg</surname><given-names>B.M.</given-names></name><name><surname>Gawel</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Botulinum toxin type A (BOTOX&#x000ae;) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial</article-title><source>Headache</source><year>2005</year><volume>45</volume><fpage>293</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2005.05066.x</pub-id><pub-id pub-id-type="pmid">15836565</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>R.</given-names></name></person-group><article-title>Peripheral and central mechanisms in tension-type headache: an update</article-title><source>Cephalalgia</source><year>2003</year><volume>23</volume><issue>Suppl.1</issue><fpage>49</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.2003.00574.x</pub-id><pub-id pub-id-type="pmid">12699459</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>K.R.</given-names></name></person-group><article-title>Evidence for antinociceptive activity of botulinum toxin type a in pain management</article-title><source>Headache</source><year>2003</year><volume>43</volume><issue>suppl1</issue><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.43.7s.3.x</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>M.</given-names></name><name><surname>Khanijou</surname><given-names>S.</given-names></name><name><surname>Rubino</surname><given-names>J.</given-names></name><name><surname>Aoki</surname><given-names>K.R.</given-names></name></person-group><article-title>Subcutaneous administration of botulinum toxin A reduces formalin-induced pain</article-title><source>Pain</source><year>2004</year><volume>107</volume><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2003.10.008</pub-id><pub-id pub-id-type="pmid">14715398</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durham</surname><given-names>P.L.</given-names></name><name><surname>Cady</surname><given-names>R.</given-names></name></person-group><article-title>Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy</article-title><source>Headache</source><year>2004</year><volume>44</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2004.04007.x</pub-id><pub-id pub-id-type="pmid">14979881</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshinsky</surname><given-names>M.L.</given-names></name><name><surname>Pozo-Rosich</surname><given-names>P.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Botulinum toxin type A blocks sensitization of neurons in the trigeminal nucleus candalis</article-title><source>Cephalalgia</source><year>2004</year><volume>24</volume><fpage>781</fpage></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>N.</given-names></name></person-group><article-title>The Prophylactic Treatment of Chronic Daily Headache</article-title><source>Headache</source><year>2006</year><volume>46</volume><fpage>1552</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00621.x</pub-id><pub-id pub-id-type="pmid">17115988</pub-id></mixed-citation></ref></ref-list></back></article>
